Dr Courtney DiNardo speaks to ecancer in an online interview for the virtual EHA 2020 meeting.
The VIALE-A trial is a a randomised, double-blind, placebo-controlled study of venetoclax with azacitidine vs azacitidine in treatment-naïve patients with acute myeloid leukaemia ineligible for intensive therapy.
Dr DiNardo provides a thorough background behind the study, before outlining the trial design and endpoints.
She then details the results including positive responses, and safety profile.
Read more about the study here.